LCI Stock Price, News & Analysis

LCI NYSE

Company Description

LCI (NYSE: LCI) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

LCI stock has declined 76.0% over the past year.

This page provides a comprehensive overview of LCI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-75.99%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

LCI (LCI) stock. Over the past 12 months, the stock has lost 76.0%.

Latest News

View All

May 1, 2023

—

Lannett Company, Inc. Enters Into Restructuring Support Agreement

April 20, 2023

—

NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS

April 4, 2023

-48.13%

LANNETT SHARES UPDATE

February 1, 2023

+25.93%

LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE

earnings

January 25, 2023

-12.90%

LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLIT

stock split

January 25, 2023

+0.96%

LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1

conferences earnings

LCI has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, stock split, conferences. View all LCI news →

SEC Filings

View All

No SEC filings available for LCI.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

LCI Company Profile & Sector Positioning

LCI (LCI) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NYSE.